EcoDrugPlus

Eph Receptor A2

Ensembl ID : ENSSARG00000001529
Gene Symbol: EPHA2
1 External references
124 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSSARG00000008065
Gene Symbol: EPHA3
1 External references
215 Possible Orthologues:

Eph Receptor B4

Ensembl ID : ENSSARG00000006693
Gene Symbol: EPHB4
1 External references
167 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSSARG00000011573
Gene Symbol: FAU
1 External references
251 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSARG00000011054
Gene Symbol: FYN
1 External references
261 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSARG00000002555
Gene Symbol: HCK
1 External references
205 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSSARG00000005676
Gene Symbol: KIT
1 External references
265 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSSARG00000007956
Gene Symbol: KRAS
1 External references
201 Possible Orthologues:

Lck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSARG00000006578
Gene Symbol: LCK
1 External references
120 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSARG00000007484
Gene Symbol: LYN
1 External references
202 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSSARG00000012735
Gene Symbol: MALT1
1 External references
195 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 1

Ensembl ID : ENSSARG00000014477
Gene Symbol: MKNK1
1 External references
167 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).